Cargando…
Polysaccharide κ-Carrageenan as Doping Agent in Conductive Coatings for Electrochemical Controlled Release of Dexamethasone at Therapeutic Doses
Smart conductive materials are developed in regenerative medicine to promote a controlled release profile of charged bioactive agents in the vicinity of implants. The incorporation and the active electrochemical release of the charged compounds into the organic conductive coating is achieved due to...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7249122/ https://www.ncbi.nlm.nih.gov/pubmed/32375224 http://dx.doi.org/10.3390/molecules25092139 |
_version_ | 1783538530971025408 |
---|---|
author | Ramírez Sánchez, Karla Ledezma-Espinoza, Aura Sánchez-Kopper, Andrés Avendaño-Soto, Esteban Prado, Mónica Starbird Perez, Ricardo |
author_facet | Ramírez Sánchez, Karla Ledezma-Espinoza, Aura Sánchez-Kopper, Andrés Avendaño-Soto, Esteban Prado, Mónica Starbird Perez, Ricardo |
author_sort | Ramírez Sánchez, Karla |
collection | PubMed |
description | Smart conductive materials are developed in regenerative medicine to promote a controlled release profile of charged bioactive agents in the vicinity of implants. The incorporation and the active electrochemical release of the charged compounds into the organic conductive coating is achieved due to its intrinsic electrical properties. The anti-inflammatory drug dexamethasone was added during the polymerization, and its subsequent release at therapeutic doses was reached by electrical stimulation. In this work, a Poly (3,4-ethylenedioxythiophene): κ-carrageenan: dexamethasone film was prepared, and κ-carrageenan was incorporated to keep the electrochemical and physical stability of the electroactive matrix. The presence of κ-carrageenan and dexamethasone in the conductive film was confirmed by µ-Raman spectroscopy and their effect in the topographic was studied using profilometry. The dexamethasone release process was evaluated by cyclic voltammetry and High-Resolution mass spectrometry. In conclusion, κ-carrageenan as a doping agent improves the electrical properties of the conductive layer allowing the release of dexamethasone at therapeutic levels by electrochemical stimulation, providing a stable system to be used in organic bioelectronics systems. |
format | Online Article Text |
id | pubmed-7249122 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-72491222020-06-10 Polysaccharide κ-Carrageenan as Doping Agent in Conductive Coatings for Electrochemical Controlled Release of Dexamethasone at Therapeutic Doses Ramírez Sánchez, Karla Ledezma-Espinoza, Aura Sánchez-Kopper, Andrés Avendaño-Soto, Esteban Prado, Mónica Starbird Perez, Ricardo Molecules Article Smart conductive materials are developed in regenerative medicine to promote a controlled release profile of charged bioactive agents in the vicinity of implants. The incorporation and the active electrochemical release of the charged compounds into the organic conductive coating is achieved due to its intrinsic electrical properties. The anti-inflammatory drug dexamethasone was added during the polymerization, and its subsequent release at therapeutic doses was reached by electrical stimulation. In this work, a Poly (3,4-ethylenedioxythiophene): κ-carrageenan: dexamethasone film was prepared, and κ-carrageenan was incorporated to keep the electrochemical and physical stability of the electroactive matrix. The presence of κ-carrageenan and dexamethasone in the conductive film was confirmed by µ-Raman spectroscopy and their effect in the topographic was studied using profilometry. The dexamethasone release process was evaluated by cyclic voltammetry and High-Resolution mass spectrometry. In conclusion, κ-carrageenan as a doping agent improves the electrical properties of the conductive layer allowing the release of dexamethasone at therapeutic levels by electrochemical stimulation, providing a stable system to be used in organic bioelectronics systems. MDPI 2020-05-03 /pmc/articles/PMC7249122/ /pubmed/32375224 http://dx.doi.org/10.3390/molecules25092139 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Ramírez Sánchez, Karla Ledezma-Espinoza, Aura Sánchez-Kopper, Andrés Avendaño-Soto, Esteban Prado, Mónica Starbird Perez, Ricardo Polysaccharide κ-Carrageenan as Doping Agent in Conductive Coatings for Electrochemical Controlled Release of Dexamethasone at Therapeutic Doses |
title | Polysaccharide κ-Carrageenan as Doping Agent in Conductive Coatings for Electrochemical Controlled Release of Dexamethasone at Therapeutic Doses |
title_full | Polysaccharide κ-Carrageenan as Doping Agent in Conductive Coatings for Electrochemical Controlled Release of Dexamethasone at Therapeutic Doses |
title_fullStr | Polysaccharide κ-Carrageenan as Doping Agent in Conductive Coatings for Electrochemical Controlled Release of Dexamethasone at Therapeutic Doses |
title_full_unstemmed | Polysaccharide κ-Carrageenan as Doping Agent in Conductive Coatings for Electrochemical Controlled Release of Dexamethasone at Therapeutic Doses |
title_short | Polysaccharide κ-Carrageenan as Doping Agent in Conductive Coatings for Electrochemical Controlled Release of Dexamethasone at Therapeutic Doses |
title_sort | polysaccharide κ-carrageenan as doping agent in conductive coatings for electrochemical controlled release of dexamethasone at therapeutic doses |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7249122/ https://www.ncbi.nlm.nih.gov/pubmed/32375224 http://dx.doi.org/10.3390/molecules25092139 |
work_keys_str_mv | AT ramirezsanchezkarla polysaccharidekcarrageenanasdopingagentinconductivecoatingsforelectrochemicalcontrolledreleaseofdexamethasoneattherapeuticdoses AT ledezmaespinozaaura polysaccharidekcarrageenanasdopingagentinconductivecoatingsforelectrochemicalcontrolledreleaseofdexamethasoneattherapeuticdoses AT sanchezkopperandres polysaccharidekcarrageenanasdopingagentinconductivecoatingsforelectrochemicalcontrolledreleaseofdexamethasoneattherapeuticdoses AT avendanosotoesteban polysaccharidekcarrageenanasdopingagentinconductivecoatingsforelectrochemicalcontrolledreleaseofdexamethasoneattherapeuticdoses AT pradomonica polysaccharidekcarrageenanasdopingagentinconductivecoatingsforelectrochemicalcontrolledreleaseofdexamethasoneattherapeuticdoses AT starbirdperezricardo polysaccharidekcarrageenanasdopingagentinconductivecoatingsforelectrochemicalcontrolledreleaseofdexamethasoneattherapeuticdoses |